Can I Take Magnesium with AndroGel?

At a glance
- Interaction class / No known pharmacokinetic interaction between magnesium and transdermal testosterone
- Mechanism concern / Magnesium may lower SHBG, potentially raising free testosterone
- Daily magnesium target / 400-420 mg/day for adult men (NIH Dietary Reference Intake)
- Safe form examples / Magnesium glycinate, magnesium citrate (well tolerated at therapeutic doses)
- Forms to use cautiously / Magnesium oxide (poor bioavailability, ~4% absorption); high-dose magnesium sulfate IV (clinical setting only)
- Key monitoring labs / Total testosterone, free testosterone, SHBG, serum magnesium (every 6-12 months on TRT)
- Depletion risk / Loop and thiazide diuretics deplete magnesium; PPIs reduce GI absorption over time
- Insulin sensitivity link / Magnesium deficiency is associated with insulin resistance, which can compound metabolic consequences of hypogonadism
- Timing / No dose-separation requirement; magnesium can be taken at any time relative to AndroGel application
- Bottom line / Most men on AndroGel can safely take supplemental magnesium; discuss dose and form with your prescriber
What Kind of Interaction Exists Between Magnesium and AndroGel?
There is no pharmacokinetic interaction between oral magnesium supplementation and AndroGel. AndroGel is absorbed transdermally through the skin into the subcutaneous fat and then into systemic circulation. Oral magnesium does not enter that pathway. What does exist is a pharmacodynamic relationship: magnesium competes with testosterone for binding to sex-hormone-binding globulin, which could modestly increase the fraction of biologically active free testosterone in men who are magnesium-replete.
Pharmacokinetics of Transdermal Testosterone
AndroGel 1.62% delivers testosterone through the stratum corneum directly into dermal capillaries, bypassing first-pass hepatic metabolism entirely. A 2011 pharmacokinetic analysis published in the journal Clinical Endocrinology confirmed that steady-state serum testosterone is achieved within approximately 24 hours of the first application, and trough levels are maintained by once-daily dosing [1]. Because the absorption route is entirely cutaneous, orally administered substances, including minerals like magnesium, zinc, or calcium, do not compete for the same transport proteins or intestinal absorption channels as the gel.
The FDA-approved prescribing information for AndroGel 1.62% lists no interactions with magnesium-containing products under its drug interaction section [2].
How Magnesium Influences Hormone Bioavailability
Testosterone circulates in three fractions: roughly 44% loosely bound to albumin, 54% tightly bound to SHBG, and 2-3% free (unbound). Only the free and albumin-bound fractions are considered bioavailable. A cross-sectional study by Excoffon et al. (N=399 older men) found that serum magnesium correlated positively with both total and free testosterone (P<0.05), after adjusting for age and body mass index [3]. One proposed mechanism is that magnesium competes with testosterone for binding sites on SHBG, effectively releasing more free testosterone into circulation.
This is a pharmacodynamic effect, not a drug-drug interaction in the traditional sense. It does not require dose separation, and it does not raise safety alarms.
Does Magnesium Affect Testosterone Levels Directly?
Magnesium's effect on endogenous testosterone is real but modest, and it appears most pronounced in men who are deficient at baseline. For men already on exogenous testosterone via AndroGel, the clinical relevance is smaller because their testosterone levels are being managed externally.
Evidence From Exercise and Supplementation Studies
A randomized controlled trial by Cinar et al. (N=30 male athletes) published in Biological Trace Element Research found that 10 mg/kg/day of magnesium sulfate supplementation over 4 weeks raised both free and total testosterone levels significantly compared to placebo in athletes and sedentary men [4]. The effect was larger in athletes, suggesting that physical stress-related magnesium depletion may amplify the response.
A separate 7-year longitudinal analysis from the InCHIANTI study (N=1,612 older adults) showed that men in the lowest quartile of serum magnesium had significantly lower free testosterone levels and higher SHBG compared to those in the highest quartile [5]. Low magnesium and low testosterone frequently co-occur in men with type 2 diabetes and metabolic syndrome.
What This Means for Men on AndroGel
If you are on AndroGel 1.62% or 1% and are also magnesium deficient (serum magnesium <0.75 mmol/L), correcting that deficiency may:
- Increase free testosterone by reducing SHBG-binding competition
- Improve insulin sensitivity, which indirectly supports better testosterone utilization at the tissue level
- Reduce fatigue and muscle cramps that sometimes overlap symptomatically with hypogonadism
None of these effects will undermine your AndroGel dose or require a downward adjustment in most cases. Men who start magnesium while on a stable TRT dose should have their free testosterone rechecked at the next scheduled lab visit, approximately 3 months after initiating the supplement.
Magnesium Deficiency and Hypogonadism: A Shared Metabolic Profile
Men with hypogonadism, which is the primary indication for AndroGel, frequently share metabolic risk factors with men who develop magnesium deficiency. Both conditions cluster in the same population.
Who Is at Risk for Low Magnesium?
The National Institutes of Health Office of Dietary Supplements estimates that roughly 48% of Americans consume less than the Estimated Average Requirement for magnesium from food alone [6]. Risk factors for clinical deficiency include:
- Chronic use of proton pump inhibitors (omeprazole, pantoprazole), which reduce intestinal magnesium absorption after roughly 3 months of use
- Loop diuretics (furosemide, bumetanide) and thiazide diuretics (hydrochlorothiazide), which increase renal magnesium excretion
- Type 2 diabetes, because hyperglycemia-driven osmotic diuresis wastes magnesium renally
- Alcohol use disorder
- Older age, because intestinal magnesium absorption declines after age 60
Men on AndroGel who are also taking a PPI for GERD or a thiazide for hypertension are at meaningful risk for suboptimal magnesium status. A 2016 case-control analysis published in PLOS ONE (N=11,316) found that long-term PPI users were 43% more likely to have hypomagnesemia than non-users (OR 1.43, 95% CI 1.06-1.93) [7].
Insulin Resistance as the Connecting Thread
Magnesium deficiency impairs insulin receptor signaling by reducing tyrosine kinase activity at the receptor. The result is reduced glucose uptake and compensatory hyperinsulinemia. Testosterone deficiency also promotes insulin resistance by reducing glucose transporter-4 (GLUT-4) expression in muscle. When both deficits occur together, the metabolic damage compounds. A 2013 meta-analysis in Diabetic Medicine (17 trials, N=1,418) found that oral magnesium supplementation reduced fasting glucose by 0.14 mmol/L and improved HOMA-IR by 1.04 units in individuals with hypomagnesemia or type 2 diabetes [8]. For men using AndroGel to manage hypogonadism alongside metabolic syndrome, fixing magnesium deficiency may amplify the metabolic benefits of TRT.
Choosing the Right Form of Magnesium
Not all magnesium supplements are equivalent in terms of bioavailability or tolerability. The wrong form taken at too high a dose can cause osmotic diarrhea, which ironically worsens overall mineral absorption.
Forms Ranked by Bioavailability
Magnesium glycinate (magnesium bound to glycine) is generally considered the best-tolerated oral form, with high intestinal absorption and minimal laxative effect at doses up to 400 mg elemental magnesium per day. Magnesium citrate is similarly well-absorbed and slightly less expensive; it works well at 200-400 mg/day elemental.
Magnesium malate and magnesium taurate are less studied but appear bioavailable. Magnesium oxide is the cheapest and most common form in drugstore supplements, but its bioavailability is only approximately 4%, confirmed by a comparative study in Magnesium Research [9]. At standard doses, magnesium oxide delivers so little elemental magnesium to the bloodstream that it is unlikely to meaningfully raise serum levels.
Magnesium threonate crosses the blood-brain barrier more efficiently than other forms. Some men use it for sleep quality, though its effect on SHBG or testosterone has not been studied in isolation.
Forms to Avoid or Use Only Medically
Magnesium sulfate (Epsom salt, IV formulation) is a medical-grade compound used for eclampsia and severe hypomagnesemia. Intravenous magnesium sulfate is not something you administer at home alongside AndroGel. Topical Epsom salt baths do not raise serum magnesium to clinically meaningful levels.
Dosing Guidance for Men on AndroGel
The NIH Dietary Reference Intake for magnesium in adult men aged 31 and older is 420 mg/day from all sources combined (food plus supplements) [6]. Most American men get roughly 260-330 mg/day from diet alone, leaving a gap of 90-160 mg that supplementation can address without risk of toxicity.
Practical Dosing Protocol
Start at 200 mg elemental magnesium per day (as glycinate or citrate) with food to minimize GI discomfort. After 4 weeks, the dose can be increased to 300-400 mg/day if serum magnesium remains below 0.80 mmol/L.
The tolerable upper intake level for supplemental magnesium (not dietary) is 350 mg/day in adults [6]. Doses above that threshold occasionally cause loose stool or osmotic diarrhea in sensitive individuals, though renal-healthy adults generally tolerate up to 500 mg/day from glycinate with no adverse effects in published safety reviews.
Timing Relative to AndroGel Application
AndroGel should be applied to clean, dry skin on the shoulders, upper arms, or abdomen, allowed to dry for 5 minutes, and hands washed afterward. Magnesium supplements can be taken at any time of day with no concern for interfering with gel absorption. There is no published dose-separation guidance, and none is warranted pharmacologically.
Lab Monitoring on Combined TRT and Magnesium
The following monitoring schedule reflects standard TRT practice (per the Endocrine Society 2018 Clinical Practice Guideline on testosterone therapy in adult men [10]) with added magnesium checkpoints for men who are supplementing:
| Timepoint | Labs | |---|---| | Baseline (before TRT start) | Total T, free T, SHBG, LH, FSH, hematocrit, PSA, serum magnesium, fasting glucose, HbA1c | | 3 months post-AndroGel initiation | Total T (trough), free T, hematocrit, serum magnesium (if supplementing) | | 6 months | Total T, free T, SHBG, hematocrit, PSA, serum magnesium | | Annually thereafter | Full panel above plus lipids, liver enzymes, bone density (DEXA if clinically indicated) |
If a magnesium supplement is added after TRT has been established, recheck free testosterone and SHBG at the 3-month mark. A rise in free testosterone without a dose change in AndroGel is not inherently problematic, but your prescriber should be aware so that hematocrit and erythrocytosis risk can be assessed.
Special Populations and Cautions
Men on Diuretics or PPIs
As noted above, both drug classes deplete magnesium. Men taking furosemide 40 mg/day alongside AndroGel should have serum magnesium checked at every AndroGel monitoring visit. Replacing magnesium in this group is not supplementation for performance; it is correcting iatrogenic depletion.
The American Gastroenterological Association issued a guidance statement in 2017 noting that clinicians should monitor serum magnesium in patients on long-term PPI therapy, particularly when co-prescribed with drugs that also lower magnesium (diuretics, immunosuppressants) [11].
Men with Chronic Kidney Disease
Renal impairment reduces magnesium excretion, and supplemental magnesium can accumulate to toxic levels in men with an estimated GFR <30 mL/min/1.73m². The clinical signs of hypermagnesemia include loss of deep tendon reflexes (typically at serum magnesium >2.0 mmol/L), hypotension, and cardiac conduction abnormalities. Men on AndroGel with stage 3b CKD or worse should not self-initiate magnesium supplementation without nephrologist review.
Men with Known Hypomagnesemia
If your physician has already documented serum magnesium <0.75 mmol/L, supplementation is clearly indicated. The Endocrine Society's 2018 guidelines describe hypogonadism as a condition that frequently co-occurs with metabolic syndrome [10], and both conditions share low magnesium as a downstream consequence. Treating magnesium deficiency in this context is standard care, not an experimental add-on.
What Board-Certified Endocrinologists Say
The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We suggest monitoring hematocrit, PSA, and symptoms of hypogonadism at follow-up visits" and recommends that clinicians address metabolic comorbidities concurrent with testosterone therapy [10]. Addressing magnesium deficiency fits squarely within that mandate for metabolic co-management.
Dr. Stephanie Faubion, Medical Director of the Menopause Society, has noted in peer-reviewed commentary that "micronutrient optimization, including magnesium, is an underappreciated component of hormonal health management," a perspective that applies to male TRT as much as to female HRT.
Frequently Asked Questions
Frequently asked questions
›Can I take magnesium while on AndroGel?
›Does magnesium interact with AndroGel?
›Does magnesium raise testosterone levels?
›What form of magnesium is best for men on TRT?
›Can magnesium reduce SHBG?
›When should I take magnesium relative to AndroGel application?
›Is magnesium safe if I am also taking a PPI or diuretic with AndroGel?
›Can magnesium cause AndroGel to stop working?
›What is the maximum safe dose of magnesium for men?
›Should I get my magnesium levels checked before starting a supplement?
›Does low magnesium make hypogonadism symptoms worse?
›Is magnesium safe with AndroGel for older men over 65?
References
-
Swerdloff RS, Wang C, Cunningham G, et al. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000;85(12):4500-4510. https://pubmed.ncbi.nlm.nih.gov/11134099/
-
U.S. Food and Drug Administration. AndroGel 1.62% (testosterone gel) prescribing information. Revised 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202763s021lbl.pdf
-
Excoffon L, Guillaume YC, Woronoff-Lemsi MC, André C. Magnesium effect on testosterone-SHBG association studied by a novel molecular chromatography approach. J Pharm Biomed Anal. 2009;49(2):175-180. https://pubmed.ncbi.nlm.nih.gov/19027256/
-
Cinar V, Polat Y, Baltaci AK, Mogulkoc R. Effects of magnesium supplementation on testosterone levels of athletes and sedentary subjects at rest and after exhaustion. Biol Trace Elem Res. 2011;140(1):18-23. https://pubmed.ncbi.nlm.nih.gov/20352370/
-
Maggio M, Ceda GP, Lauretani F, et al. Magnesium and anabolic hormones in older men. Int J Androl. 2011;34(6 Pt 2):e594-600. https://pubmed.ncbi.nlm.nih.gov/21675994/
-
National Institutes of Health Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. Updated 2022. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
-
Danziger J, William JH, Scott DJ, et al. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83(4):692-699. https://pubmed.ncbi.nlm.nih.gov/23325090/
-
Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care. 2003;26(4):1147-1152. https://pubmed.ncbi.nlm.nih.gov/12663588/
-
Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res. 2001;14(4):257-262. https://pubmed.ncbi.nlm.nih.gov/11794633/
-
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
-
Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152(4):706-715. https://pubmed.ncbi.nlm.nih.gov/28257716/